Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
EnBio Holdings, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 59%, Exceeds Full-Year Plan
6092 EnBio Holdings,Inc 【J-GAAP】
Earnings ReportEnBio Holdings,Inc <6092> [TSE Std] announced its financial results after the market closed on February 14th (16:00). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) expanded 869 million yen, an increase 59.2% compared to the same period last year. The progress rate toward the full-year plan of 674 million yen is 128.9%, already exceeding the target and also exceeding the five-year average of 87.7%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit/loss for the January to March period (4Q) is expected to turn into a loss of 195 million yen (compared to a profit of 521 million yen in the same period last year).
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit/loss turned to a profit of 230 million yen (compared to a loss of 2 million yen in the same period last year). However, the operating profit margin worsened from 3.9% in the same period last year to 2.8%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 6,771 | 1,360 | 1,368 | 856 | 129.0 | 101.9 | Feb 13, 2023 | J-GAAP |
Apr - Dec, 2023 | 6,986 | 467 | 546 | 345 | 43.6 | 51.2 | Feb 14, 2024 | J-GAAP |
Apr - Dec, 2024 | 8,191 | 835 | 869 | 565 | 69.8 | 128.9 | Feb 14, 2025 | J-GAAP |
YoY | +17.2% | +78.8% | +59.2% | +63.8% | +60.3% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 4,093 | 406 | 519 | 387 | 48.6 | 8 | May 15, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 4,954 | 46 | 35 | 35 | 4.3 | 8 | Nov 14, 2024 | J-GAAP |
YoY | +21.0% | -88.7% | -93.3% | -91.0% | -91.1% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 8,120 | 1,357 | 1,343 | 812 | 122.3 | 8 | May 15, 2023 | J-GAAP |
Mar, 2024 | 9,575 | 815 | 1,067 | 708 | 88.9 | 8 | May 15, 2024 | J-GAAP |
Mar, 2025 Guidance | 10,913 | 818 | 674 | 450 | 55.6 | 8 | Nov 14, 2024 | J-GAAP |
YoY | +14.0% | +0.4% | -36.8% | -36.4% | -37.5% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 1,504 | 58 | -2 | 24 | 3.0 | 3.9 | Feb 14, 2024 | J-GAAP |
Jan - Mar, 2024 | 2,589 | 348 | 521 | 363 | 45.6 | 13.4 | May 15, 2024 | J-GAAP |
Apr - Jun, 2024 | 2,997 | 395 | 513 | 351 | 43.3 | 13.2 | Aug 14, 2024 | J-GAAP |
Jul - Sep, 2024 | 2,962 | 377 | 126 | 64 | 7.9 | 12.7 | Nov 14, 2024 | J-GAAP |
Oct - Dec, 2024 | 2,232 | 63 | 230 | 150 | 18.5 | 2.8 | Feb 14, 2025 | J-GAAP |
YoY | +48.4% | +8.6% | - | +525.0% | +511.6% |
Related Articles
IRRC, Oct-Dec (2Q) Ordinary Profit Decreases by 49%
MITSUI MATSUSHIMA, The Current Fiscal Year Ordinary Profit Revised Upward by 24%, Dividend Revised Upward by 30 yen
adish, Returning to Profitability This Year
Cytori Cell Research Institute, The Current Fiscal Year Net Income Revised Downward to a Loss, 37% Deficit Against Net Assets, Decides to Continue No Dividend Policy
LIBERTA, 6.0 times Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 1 yen
Green Monster, First Half Ordinary Profit Turns to Loss, Oct-Dec Ordinary Profit Decreases by 70%
Precision System Science, The Current Fiscal Year Ordinary Profit Loss Widened in Downward Revision
OPTORUN, 5% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen
4Cs HD, Oct-Dec (1Q) Ordinary Profit Loss Narrows
ULURU, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 48%, Oct-Dec Ordinary Profit Decreases by 27%